RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Prostate Cancer Drug Discoveries: What the Future Holds
Nov 2009 - 160 pages - $2,265
Jevtana (Cabazitaxel) - Positive Recommendation in the EU for Metastatic Castration-Resistant Prostate Cancer
Mar 2011 - 5 pages - $500
FDA Approves Zytiga (Abiraterone Acetate) for the Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer
May 2011 - 5 pages - $500
Epidemiology: Prostate Cancer – Incidence and prevalence reaches new heights due to testing, risk factors, and an aging population
Mar 2011 - 34 pages - $5,700
Endothelin A Receptor Antagonist (atrasentan) Fails to Demonstrate an Advantage in the Treatment of Advanced Prostate Cancer
May 2011 - 5 pages - $500
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
Mar 2011 - 120 pages - $3,500
Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential
Dec 2010 - 126 pages - $3,500
Company Financials: Cougar Biotechnology, Inc.
Jan 2010 - $75
Prostate Cancer Therapy Area Pipeline Report
Nov 2010 - 1011 pages - $1,495
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
More Related Market Research Reports >>>

Your selection

Industry sector
Service del
Business services del
Therapeutic target
Oncology del
Prostate cancer del
Adenocarcinoma del
Year
2002 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us